Skip to content

FDMT4D MOLECULAR THERAPEUTICS IN

CUSIP 35104E100 · common stock

2 tracked investors held 4D MOLECULAR THERAPEUTICS IN (FDMT) at the end of Q3 2026, worth $73.1M in total. The largest holder was RA Capital Management, with 0.7% of its portfolio.

Holders · Q3 2026
2
New holders
0
Value held
$73.1M
Quarter-end price (est.)
$14.31

Investors holding FDMT · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
0.72%5,049,779$72.3MHOLD
Ken Fisher
Fisher Asset Management, LLC
0.00%58,546$837.8KREDUCE-11.0%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026200$73.1M$14.31
Q2 2026211$68M$13.30
Q1 2026201$48.1M$9.31
Q4 2025300$46.8M$7.50